Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability
Source abstract
Abstract
Poly(ethylenimine) (PEI) was used to transfect the endothelial cell line EA.hy 926, and the secreted levels of three gene products, tissue-type plasminogen activator (tPA), plasminogen activator inhibitor type 1 (PAI-1), and von Willebrand Factor (vWF), were assessed via ELISA. We found that the levels of these gene products in cell supernatants increased by factors up to 16.3 (tPA), 8.3 (PAI-1), or 6.7 (vWF) times the levels recorded for untreated cells, and roughly correlated with the percentage of cells that expressed the reporter plasmid. Transfections carried out using promotorless constructs of the same reporter plasmid also yielded increases in tPA, PAI-1, and vWF to similar extents. Additionally, data regarding cell viability were gathered and found to inversely relate to both the effectiveness of the PEI used for transfection and the secreted levels of the three mentioned products. There appeared to be two distinct types of cell death, resulting from the use of either free PEI (which acts within 2 h) or PEI/DNA complexes (which cause death 7-9 h after transfection). Cells were also transfected by poly(L-lysine) and liposomal carriers, and increases in secreted tPA similar to those seen with PEI-mediated transfection were observed for positively transfected cells. The results of these investigations indicate that non-viral gene delivery can induce a state of endothelial cell dysfunction, and that PEI-mediated transfection can lead to two distinct types of cell death.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Virus-based gene therapy research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (24)
Show source-provided references
1. Review10.1016/S0168-3659(99)00090-5 ↗
2. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery10.1073/pnas.96.9.5177 ↗
3. Nanoscopic structure of DNA condensed for gene delivery10.1093/nar/25.15.3095 ↗
4. Direct observation of the biphasic conformational change of DNA induced by cationic polymers10.1016/0014-5793(91)81386-M ↗
5. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells10.1002/ijc.2910170110 ↗
6. Permanent cell line expressing human factor VIII-related antigen established by hybridization10.1073/pnas.80.12.3734 ↗
7. Prostacyclin expression by a continuous human cell line derived from vascular endothelium10.1182/blood.V68.4.825.825 ↗
9. Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency10.1038/sj.gt.3300976 ↗
10. Polyethyleneimine is an effective permeabilizer of gram-negative bacteria10.1099/00221287-143-10-3193 ↗
11. Permeabilizing action of polyethylenimine on salmonella typhimurium involves disruption of the outer membrane with lipopolysaccharide10.1099/00221287-144-2-385 ↗
12. The fusogenic effect of synthetic polycations on negatively charged lipid bilayers10.1093/oxfordjournals.jbchem.a121806 ↗
13. Endothelial cell activation in cutaneous vasculitis10.1111/j.1365-2230.1996.tb00007.x ↗
14. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria10.1161/01.ATV.15.8.1114 ↗
15. Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy10.1016/0049-3848(90)90119-W ↗
16. Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia10.1002/ajh.2830440208 ↗
17. Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells10.1083/jcb.104.5.1423 ↗
18. Intracellular trafficking of factor VIII to von Willebrand factor storage granules10.1172/JCI1250 ↗
19. An endothelial storage granule for tissue-type plasminogen activator10.1083/jcb.139.1.245 ↗
20. Calcium-dependent stabilization of type I plasminogen activator inhibitor within platelet α-granules10.1074/jbc.271.5.2754 ↗
21. Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line10.1182/blood.V87.12.5061.bloodjournal87125061 ↗
22. Induction of interferon synthesis and activation of interferon-stimulated genes by liposomal transfection reagents10.1089/jir.1998.18.947 ↗
23. Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes10.1016/0005-2736(95)00219-7 ↗
24. Poly(ethylenimine)-mediated transfection10.1002/1097-4636(20000905)51:3<321::AID-JBM5>3.3.CO;2-I ↗